Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

In a workshop overlooking paddy fields on the eastern edge of Java, Dimas Firmansyah is tinkering away on a large truck engine. A lanky 18-year-old in a hard hat and work shirt, he hopes to find a job ...